Author:
Mansuri Zeeshan,Ashraf Hadiah,Taikadan Thahsin,Rajith Gokul,Ayesha Ayesha,Fatima Urooj,Erzinger Gabriel
Reference21 articles.
1. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;J Lawton;J Am Coll Cardiol,2022
2. Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES;B R Brodie;Circ Cardiovasc Interv,2015
3. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;L Wallentin;N Engl J Med,2009
4. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial;P Vranckx;Windecker S; GLOBAL LEADERS Investigators,2018
5. Ticagrelor with or without Aspirin in High-Risk Patients after PCI;R Mehran;N Engl J Med,2019